Nexgel (NXGL) Non Operating Investment Income (2022 - 2024)

Nexgel (NXGL) reported Non Operating Investment Income of $5000.0 for Q3 2024, down 88.64% on a YoY basis from $44000.0 in Q4 2023, and down 78.26% quarter-over-quarter from $23000.0 in Q2 2024.

Nexgel (NXGL) Non Operating Investment Income (2022 - 2024) Analysis & Trends

Nexgel has reported Non Operating Investment Income for 3 years, with the latest figure at $5000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -
10 Nexgel 4.18 Mn 2.81 Mn 819,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2024 5,000.00
Sep 30, 2024 5,000.00
Jun 30, 2024 23,000.00
Jun 30, 2024 23,000.00
Sep 30, 2023 44,000.00
Sep 30, 2023 44,000.00
Jun 30, 2023 116,000.00
Jun 30, 2023 116,000.00
Sep 30, 2022 5,000.00
Sep 30, 2022 5,000.00